-1722T/C polymorphism (rs733618) of CTLA-4 significantly associated with systemic lupus erythematosus (SLE): A comprehensive meta-analysis

Human Immunology

Volumn 74, Issue 3, 2013, Pages 341-347

  Liu, Jie ^a   Zhang, Hongxin ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ALLELE; ARTICLE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROBABILITY; RANDOM ERROR; SAMPLE SIZE; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

CTLA-4 ANTIGEN; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84873705531     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.12.009     Document Type: Article

References (44)

1. Brunet J.F., Denizot F., Luciani M.F. A new member of the immunoglobulin superfamily-CTLA-4. Nature 1987, 328:267-270.
2. Kucharska A.M., Gorska E., Wasik M., Pyrzak B., Demkow U. Expression of CD152 (CTLA-4) in children with autoimmune thyroiditis and +49A/G polymorphism of exon 1 of the CTLA-4 gene. J Physiol Pharmacol 2009, 60:77-80.
3. Lindsten T., Lee K.P., Harris E.S., Petryniak B., Craighead N., Reynolds P.J., et al. Characterization of CTLA-4 structure and expression on human T cells. J Immunol 1993, 151:3489-3499.
4. Greenwald R.J., Oosterwegel M.A., van der Woude D., Kubal A., Mandelbrot D.A., Boussiotis V.A., et al. CTLA-4 regulates cell cycle progression during a primary immune response. Eur J Immunol 2002, 32:366-373.
5. Perkins D., Wang Z., Donovan C., He H., Mark D., Guan G., et al. Regulation of CTLA-4 expression during T cell activation. J Immunol 1996, 156:4154-4159.
6. Balzano C., Buonavista N., Rouvier E., Golstein P. CTLA-4 and CD28: similar proteins, neighbouring genes. Int J Cancer Suppl 1992, 7:28-32.
7. Pentcheva-Hoang T., Egen J.G., Wojnoonski K., Allison J.P. B7-1 and B7-2 selectively recruit CTLA-4 and CD28 to the immunological synapse. Immunity 2004, 21:401-413.
8. Greene J.L., Leytze G.M., Emswiler J., Peach R., Bajorath J., Cosand W., et al. Covalent dimerization of CD28/CTLA-4 and oligomerization of CD80/CD86 regulate T cell costimulatory interactions. J Biol Chem 1996, 271:26762-26771.
9. Chikuma S., Bluestone J.A. CTLA-4 and tolerance: the biochemical point of view. Immunol Res 2003, 28:241-253.
10. Egen J.G., Allison J.P. Cytotoxic T lymphocyte antigen-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 2002, 16:23-35.
11. Vaidya B., Pearce S. The emerging role of the CTLA-4 gene in autoimmune endocrinopathies. Eur J Endocrinol 2004, 150:619-626.
12. Kristiansen O.P., Larsen Z.M., Pociot F. CTLA-4 in autoimmune diseases: A general susceptibility gene to autoimmunity?. Genes Immun 2000, 1:170-184.
13. Rahman A., Isenberg D.A. Systemic lupus erythematosus. N Engl J Med 2008, 358:929-939.
14. O'Neill S., Cervera R. Systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2010, 24:841-855.
15. Moulton V.R., Tsokos G.C. Abnormalities of T cell signaling in systemic lupus erythematosus. Arthritis Res Ther 2011, 13:207.
16. Sebastiani G.D., Galeazzi M. Immunogenetic studies on systemic lupus erythematosus. Lupus 2009, 18:878-883.
17. Deapen D., Escalante A., Weinrib L., Horwitz D., Bachman B., Roy-Burman P., et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992, 35:311-318.
18. Brix T.H., Kyvik K.O., Christensen K., Hegedüs L. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. J Clin Endocrinol Metab 2001, 86:930-934.
19. Alarcón-Segovia D., Alarcón-Riquelme M.E., Cardiel M.H., Caeiro F., Massardo L., Villa A.R., et al. Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1177 lupus patients from the GLADEL cohort. Arthritis Rheum 2005, 52:1138-1147.
20. Hochberg M.C. The application of genetic epidemiology to systemic lupus erythematosus. J Rheumatol 1987, 14:867-869.
21. Gaffney P.M., Kearns G.M., Shark K.B., Ortmann W.A., Selby S.A., Malmgren M.L., et al. A genome-wide search for susceptibility genes in human systemic lupus erythematosus sibpair families. Proc Natl Acad Sci U S A 1998, 95:14875-14879.
22. Quintero-Del-Rio A.I., Kelly J.A., Kilpatrick J., James J.A., Harley J.B. The genetics of systemic lupus erythematosus stratified by renal disease: linkage at 10q22.3 (SLEN1), 2q34-35 (SLEN2), and 11p15.6 (SLEN3). Genes Immun 2002, (Suppl. 1):S57-S62.
23. Quintero-del-Rio A.I., Kelly J.A., Garriott C.P., Hutchings D.C., Frank S.G., Aston C.E., et al. SLEN2 (2q34-35) and SLEN1 (10q22.3) replication in systemic lupus erythematosus stratified by nephritis. Am J Hum Genet 2004, 75:346-348.
24. Heward J.M., Allahabadia A., Carr-Smith J., Daykin J., Cockram C.S., Gordon C., et al. No evidence for allelic association of a human CTLA-4 promoter polymorphism with autoimmune thyroid disease in either population-based case-control or family-based studies. Clin Endocrinol (Oxf) 1998, 9:331-334.
25. Ahmed S., Ihara K., Kanemitsu S., Nakashima H., Otsuka T., Tsuzaka K., et al. Association of CTLA-4 but not CD28 gene polymorphisms with systemic lupus erythematosus in the Japanese population. Rheumatology (Oxford) 2001, 40:662-667.
26. Liu M.F., Wang C.R., Lin L.C., Wu C.R. CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus 2001, 10:647-649.
27. Lee Y.H., Kim Y.R., Ji J.D., Sohn J., Song G.G. Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus. Lupus 2001, 10:601-605.
28. Hudson L.L., Rocca K., Song Y.W., Pandey J.P. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet 2002, 111:452-455.
29. Aguilar F., Torres B., Sánchez-Román J., Núñez-Roldán A., González-Escribano M.F. CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus. Hum Immunol 2003, 64:936-940.
30. Parks C.G., Hudson L.L., Cooper G.S., Dooley M.A., Treadwell E.L., St Clair E.W., et al. CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States. Lupus 2004, 13:784-791.
31. Xu A.P., Yi P.D., Su X.Y. The association between -1722C/T and SLE in Chinese Han Population. J First Mil Med Univ 2004, 24:1007-1012.
32. Chua K.H., Puah S.M., Chew C.H., Tan S.Y., Lian L.H. Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia. Ann Hum Biol 2010, 37:274-280.
33. Taha Khalaf A., Song J.Q., Gao T.T., Yu X.P., Lei T.C. CTLA-4 gene polymorphism and the risk of systemic lupus erythematosus in the Chinese population. J Biomed Biotechnol 2011, 2011:167395.
34. Walport M.J., Davies K.A., Botto M. C1q and systemic lupus erythematosus. Immunobiology 1998, 199:265-285.
35. Pickering M.C., Botto M., Taylor P.R., Lachmann P.J., Walport M.J. Systemic lupus erythematosus, complement deficiency, and apoptosis. Adv Immunol 2000, 76:227-324.
36. Gateva V., Sandling J.K., Hom G., Taylor K.E., Chung S.A., Sun X., et al. A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat Genet 2009, 41:1228-1233.
37. Nath S.K., Harley J.B., Lee Y.H. Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum Genet 2005, 118:225-234.
38. Lee Y.H., Harley J.B., Nath S.K. Meta-analysis of TNF-alpha promoter -308A/G polymorphism and SLE susceptibility. Eur J Hum Genet 2006, 14:364-371.
39. Bettinotti M.P., Hartung K., Deicher H., Messer G., Keller E., Weiss E.H., et al. Polymorphism of the tumor necrosis factor beta gene in systemic lupus erythematosus: TNFB-MHC haplotypes. Immunogenetics 1993, 37:449-454.
40. Colhoun H.M., McKeigue P.M., Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 2003, 361:865-872.
41. Gribben J.G., Freeman G.J., Boussiotis V.A., Rennert P., Jellis C.L., Greenfield E., et al. CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci U S A 1995, 92:811-815.
42. Waterhouse P., Penninger J.M., Timms E., Wakeham A., Shahinian A., Lee K.P. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995, 270:985-988.
43. Kristiansen O.P., Larsen Z.M., Pociot F. CTLA-4 in autoimmune diseases: A general susceptibility gene to autoimmunity?. Genes Immun 2000, 1:170-174.
44. Scalapino K.J., Daikh D.I. CTLA-4: a key regulatory point in the control of autoimmune disease. Immunol Res 2008, 223:143-155.